Mobile

An open-label, multi-center, continued access trial of investigational drug ASA404 for patients in previous ASA404 clinical trials

Mise à jour : Il y a 4 ans
Référence : EUCTR2009-016834-28

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To continue to collect and review safety data in patients who have completed at least 2 cycles of ASA404 in conjunction with a taxane-based chemotherapy in one of the following Novartis sponsored ASA404 studies until ASA404 is commercially available or the project has been discontinued:CASA404A2105, CASA404A2109, CASA404A2111, CASA404A2112, CASA404A2113, CASA404A1102

Critère d'inclusion

  • Solid Tumors

Liens